Literature DB >> 25648469

Clinical Monitoring in a Federally Funded Environment: Evolution and Opportunities in the Cardiovascular Cell Therapy Research Network.

Sibi R Mathew, Kristen D Lucas, Shelly L Sayre, Judy Bettencourt, Tina Collins, Dana Leach, Rachel E Olson, Doris A Taylor, Lemuel Moyé.   

Abstract

Entities:  

Year:  2014        PMID： 25648469      PMCID： PMC4308686     

Source DB:  PubMed          Journal:  Monitor (Assoc Clin Pharmacol)        ISSN： 1088-2111


× No keyword cloud information.
  5 in total

1.  The potential for central monitoring techniques to replace on-site monitoring: findings from an international multi-centre clinical trial.

Authors:  Julie M Bakobaki; Mary Rauchenberger; Nicola Joffe; Sheena McCormack; Sally Stenning; Sarah Meredith
Journal:  Clin Trials       Date:  2011-11-07       Impact factor: 2.486

Review 2.  The other side of clinical trial monitoring; assuring data quality and procedural adherence.

Authors:  George W Williams
Journal:  Clin Trials       Date:  2006       Impact factor: 2.486

3.  Improving the quality of drug research or simply increasing its cost? An evidence-based study of the cost for data monitoring in clinical trials.

Authors:  Esther Pronker; Bart F Geerts; Adam Cohen; Herman Pieterse
Journal:  Br J Clin Pharmacol       Date:  2011-03       Impact factor: 4.335

4.  Development of a network to test strategies in cardiovascular cell delivery: the NHLBI-sponsored Cardiovascular Cell Therapy Research Network (CCTRN).

Authors:  Robert D Simari; Lemuel A Moyé; Sonia I Skarlatos; Stephen G Ellis; David X M Zhao; James T Willerson; Timothy D Henry; Carl J Pepine
Journal:  J Cardiovasc Transl Res       Date:  2010-02       Impact factor: 4.132

5.  Multicenter cell processing for cardiovascular regenerative medicine applications: the Cardiovascular Cell Therapy Research Network (CCTRN) experience.

Authors:  Adrian P Gee; Sara Richman; April Durett; David McKenna; Jay Traverse; Timothy Henry; Diann Fisk; Carl Pepine; Jeannette Bloom; James Willerson; Karen Prater; David Zhao; Jane Reese Koç; Steven Ellis; Doris Taylor; Christopher Cogle; Lemuel Moyé; Robert Simari; Sonia Skarlatos
Journal:  Cytotherapy       Date:  2010-09       Impact factor: 5.414
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.